EMA seeks drug developers for adaptive licensing pilot project
By Cormac Sheridan
Thursday, March 20, 2014
The EMA hopes to sign up multiple participants to a newly launched adaptive licensing pilot project, which will explore the processes and procedures required to put in place a fully fledged scheme. There is no time limit attached to the program, which the agency unveiled this week.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.